Literature DB >> 7508458

Detection of Ehrlichia chaffeensis in human tissue by using a species-specific monoclonal antibody.

X Yu1, P Brouqui, J S Dumler, D Raoult.   

Abstract

A mouse monoclonal antibody (MAb 1A9) was produced and used in detection of Ehrlichia chaffeensis in human tissues including kidney, liver, and lung by using an indirect immunohistologic stain. MAb 1A9 was specific to E. chaffeensis and did not react with other bacteria, including Ehrlichia canis, which is the organism most closely related to E. chaffeensis. It reacted with an epitope present in two surface proteins of E. chaffeensis with molecular masses of 29 and 27 kDa. E. chaffeensis was easily detected in human tissue by immunohistology with MAb 1A9. This study demonstrates that our MAb can provide a specific and simple method for detection of E. chaffeensis in clinical specimens for establishing an etiologic diagnosis of human ehrlichiosis; it may also provide a tool for the investigation of immunopathologic characteristics in infected patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7508458      PMCID: PMC266402          DOI: 10.1128/jcm.31.12.3284-3288.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Identification of Ehrlichia in human tissue.

Authors:  J S Dumler; P Brouqui; J Aronson; J P Taylor; D H Walker
Journal:  N Engl J Med       Date:  1991-10-10       Impact factor: 91.245

2.  Antigenic characterization of ehrlichiae: protein immunoblotting of Ehrlichia canis, Ehrlichia sennetsu, and Ehrlichia risticii.

Authors:  P Brouqui; J S Dumler; D Raoult; D H Walker
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

3.  Ehrlichia ewingii sp. nov., the etiologic agent of canine granulocytic ehrlichiosis.

Authors:  B E Anderson; C E Greene; D C Jones; J E Dawson
Journal:  Int J Syst Bacteriol       Date:  1992-04

4.  Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988.

Authors:  T R Eng; J R Harkess; D B Fishbein; J E Dawson; C N Greene; M A Redus; F T Satalowich
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

5.  Human ehrlichiosis: hematopathology and immunohistologic detection of Ehrlichia chaffeensis.

Authors:  J S Dumler; J E Dawson; D H Walker
Journal:  Hum Pathol       Date:  1993-04       Impact factor: 3.466

6.  Phylogenetic position of Cowdria ruminantium (Rickettsiales) determined by analysis of amplified 16S ribosomal DNA sequences.

Authors:  A H van Vliet; F Jongejan; B A van der Zeijst
Journal:  Int J Syst Bacteriol       Date:  1992-07

7.  Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction.

Authors:  B E Anderson; J W Sumner; J E Dawson; T Tzianabos; C R Greene; J G Olson; D B Fishbein; M Olsen-Rasmussen; B P Holloway; E H George
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

8.  Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis.

Authors:  J E Dawson; B E Anderson; D B Fishbein; J L Sanchez; C S Goldsmith; K H Wilson; C W Duntley
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

9.  Ehrlichia chaffeensis, a new species associated with human ehrlichiosis.

Authors:  B E Anderson; J E Dawson; D C Jones; K H Wilson
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

10.  Serologic diagnosis of human ehrlichiosis using two Ehrlichia canis isolates.

Authors:  J E Dawson; Y Rikihisa; S A Ewing; D B Fishbein
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

View more
  15 in total

Review 1.  Detection of infection or infectious agents by use of cytologic and histologic stains.

Authors:  G L Woods; D H Walker
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

2.  Immunodiagnosis of Ehrlichia canis infection with recombinant proteins.

Authors:  J W McBride; R E Corstvet; E B Breitschwerdt; D H Walker
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

3.  Western immunoblotting analysis of the antibody responses of patients with human monocytotropic ehrlichiosis to different strains of Ehrlichia chaffeensis and Ehrlichia canis.

Authors:  S M Chen; L C Cullman; D H Walker
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

4.  Comparison of Ehrlichia chaffeensis recombinant proteins for serologic diagnosis of human monocytotropic ehrlichiosis.

Authors:  X J Yu; P A Crocquet-Valdes; L C Cullman; V L Popov; D H Walker
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

5.  Genetic diversity of the 28-kilodalton outer membrane protein gene in human isolates of Ehrlichia chaffeensis.

Authors:  X J Yu; J W McBride; D H Walker
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

6.  Cytopathic effect, plaque formation, and lysis of Ehrlichia chaffeensis grown on continuous cell lines.

Authors:  P Brouqui; M L Birg; D Raoult
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Expression of members of the 28-kilodalton major outer membrane protein family of Ehrlichia chaffeensis during persistent infection.

Authors:  Jian-zhi Zhang; Hong Guo; Gary M Winslow; Xue-jie Yu
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  Serotyping isolates of Anaplasma phagocytophilum by using monoclonal antibodies.

Authors:  Hisashi Inokuma; Philippe Brouqui; J Stephen Dumler; Didier Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

9.  Serologic diagnosis of human monocytic ehrlichiosis by immunoblot analysis.

Authors:  P Brouqui; C Lecam; J Olson; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

10.  Isolation and characterization of a new strain of Ehrlichia chaffeensis from a patient with nearly fatal monocytic ehrlichiosis.

Authors:  J S Dumler; S M Chen; K Asanovich; E Trigiani; V L Popov; D H Walker
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.